These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31387437)

  • 21. Enhanced Permeation of Methotrexate via Loading into Ultra-permeable Niosomal Vesicles: Fabrication, Statistical Optimization, Ex Vivo Studies, and In Vivo Skin Deposition and Tolerability.
    Al-Mahallawi AM; Fares AR; Abd-Elsalam WH
    AAPS PharmSciTech; 2019 Apr; 20(5):171. PubMed ID: 31004239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intradermal and follicular delivery of adapalene liposomes.
    Kumar V; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanosized ethosomal dispersions for enhanced transdermal delivery of nebivolol using intradermal/transfollicular sustained reservoir:
    Fouad SA; Khatab ST; Teaima MH; El-Nabarawi MA; Abdelmonem R
    Pharm Dev Technol; 2024 Jan; 29(1):40-51. PubMed ID: 38078863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation.
    Hussain A; Samad A; Ramzan M; Ahsan MN; Ur Rehman Z; Ahmad FJ
    Drug Deliv; 2016 May; 23(4):1115-29. PubMed ID: 25379805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole:
    Nemr AA; El-Mahrouk GM; Badie HA
    J Liposome Res; 2022 Jun; 32(2):159-171. PubMed ID: 33970754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application.
    Nemr AA; El-Mahrouk GM; Badie HA
    Drug Dev Ind Pharm; 2021 Mar; 47(3):403-415. PubMed ID: 33625936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment.
    Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S
    AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposome-containing Hibiscus sabdariffa calyx extract formulations with increased antioxidant activity, improved dermal penetration and reduced dermal toxicity.
    Pinsuwan S; Amnuaikit T; Ungphaiboon S; Itharat A
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S216-26. PubMed ID: 21294418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
    Jukanti R; Sheela S; Bandari S; Veerareddy PR
    J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanostructured Ethosomal Gel Loaded with Arctostaphylosuva-Ursi Extract; In-Vitro/In-Vivo Evaluation as a Cosmeceutical Product for Skin Rejuvenation.
    Javed N; Ijaz S; Akhtar N; Khan HMS
    Curr Drug Deliv; 2022; 19(6):706-720. PubMed ID: 34325633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing glycerosome formulations
    Zhu C; Zhang Y; Wu T; He Z; Guo T; Feng N
    Acta Pharm; 2022 Mar; 72(1):135-146. PubMed ID: 36651523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.
    Albash R; Abdelbary AA; Refai H; El-Nabarawi MA
    Int J Nanomedicine; 2019; 14():1953-1968. PubMed ID: 30936696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved stability and skin penetration through glycethosomes loaded with glycyrrhetinic acid.
    Zhang Y; Liang R; Liu C; Yang C
    Int J Cosmet Sci; 2022 Apr; 44(2):249-261. PubMed ID: 35303372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and optimization of fisetin loaded glycerol based soft nanovesicles by Box-Behnken design.
    Moolakkadath T; Aqil M; Ahad A; Imam SS; Praveen A; Sultana Y; Mujeeb M
    Int J Pharm; 2020 Mar; 578():119125. PubMed ID: 32036010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes.
    Zeb A; Qureshi OS; Kim HS; Cha JH; Kim HS; Kim JK
    Int J Nanomedicine; 2016; 11():3813-24. PubMed ID: 27540293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal hydrogel formulation for transdermal delivery of pirfenidone.
    Jose A; Mandapalli PK; Venuganti VV
    J Liposome Res; 2016; 26(2):139-47. PubMed ID: 26114208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposome surface charge influence on skin penetration behaviour.
    Gillet A; Compère P; Lecomte F; Hubert P; Ducat E; Evrard B; Piel G
    Int J Pharm; 2011 Jun; 411(1-2):223-31. PubMed ID: 21458550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.